CUMBERLAND PHARMACEUTICALS INC Quarterly Selling and Marketing Expense in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Cumberland Pharmaceuticals Inc quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2010 to Q2 2024.
  • Cumberland Pharmaceuticals Inc Selling and Marketing Expense for the quarter ending June 30, 2024 was $4.25M, a 9.07% decline year-over-year.
  • Cumberland Pharmaceuticals Inc Selling and Marketing Expense for the twelve months ending June 30, 2024 was $17.9M, a 8.92% increase year-over-year.
  • Cumberland Pharmaceuticals Inc annual Selling and Marketing Expense for 2023 was $18.5M, a 10.7% increase from 2022.
  • Cumberland Pharmaceuticals Inc annual Selling and Marketing Expense for 2022 was $16.7M, a 11% increase from 2021.
  • Cumberland Pharmaceuticals Inc annual Selling and Marketing Expense for 2021 was $15M, a 1.69% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $17.9M $4.25M -$424K -9.07% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $18.3M $4.15M -$123K -2.87% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $18.5M $4.76M +$1.38M +40.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $17.1M $4.74M +$633K +15.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $16.4M $4.67M +$115K +2.53% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $16.3M $4.28M -$337K -7.31% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $16.7M $3.38M +$73.5K +2.22% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $16.6M $4.11M +$310K +8.16% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $16.3M $4.56M +$435K +10.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $15.8M $4.61M +$827K +21.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $15M $3.31M -$299K -8.28% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 $15.3M $3.8M +$212K +5.92% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $15.1M $4.12M +$256K +6.63% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $14.8M $3.79M +$79.7K +2.15% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $14.8M $3.6M -$441K -10.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $15.2M $3.59M -$225K -5.89% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $15.4M $3.87M -$117K -2.94% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $15.5M $3.71M +$271K +7.88% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $15.3M $4.05M +$4.59M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $10.7M $3.81M -$991K -20.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $11.7M $3.98M -$1.09M -21.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $12.8M $3.44M -$1.23M -26.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 $14M -$545K +$2.14M +79.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $11.9M $4.8M -$1.42M -22.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $13.3M $5.08M +$421K +9.05% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $12.9M $4.67M -$623K -11.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $13.5M -$2.69M -$6.65M -168% Oct 1, 2017 Dec 31, 2017 8-K 2020-12-10
Q3 2017 $20.1M $6.23M +$2.61M +72.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $17.5M $4.65M +$1.38M +42.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $16.1M $5.29M +$1.59M +43.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $14.6M $3.97M +$618K +18.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 $13.9M $3.61M +$5.89K +0.16% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $13.9M $3.27M -$233K -6.65% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $14.2M $3.7M +$168K +4.76% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $14M $3.35M -$187K -5.28% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 $14.2M $3.61M -$213K -5.58% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $14.4M $3.51M -$425K -10.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $14.8M $3.53M -$83K -2.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $14.9M $3.54M -$225K -5.99% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-13
Q3 2014 $15.1M $3.82M +$412K +12.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $14.7M $3.93M +$388K +11% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $14.3M $3.61M -$60K -1.63% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $14.4M $3.76M -$1.18M -23.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 $15.6M $3.41M -$1.5M -30.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $17.1M $3.54M -$1.95M -35.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $19M $3.67M -$1.31M -26.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $20.3M $4.94M +$256K +5.46% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-09
Q3 2012 $20.1M $4.91M -$146K -2.89% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 $20.2M $5.49M -$412K -6.99% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $20.6M $4.98M -$308K -5.82% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $20.9M $4.69M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-11
Q3 2011 $5.06M -$632K -11.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 $5.9M +$56.3K +0.96% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $5.29M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 $5.69M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $5.85M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.